Zinc-finger antiviral protein inhibits XMRV infection

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Wang, Xinlu ^a   Tu, Fan ^a,b   Zhu, Yiping ^a   Gao, Guangxia ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; MESSENGER RNA; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS RNA; ZINC FINGER ANTIVIRAL PROTEIN;

3' UNTRANSLATED REGION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; DRUG INHIBITION; DRUG PROTEIN BINDING; GENE MAPPING; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RETROVIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; XENOTROPIC MULV RELATED VIRUS;

CPG ISLANDS; DOWN-REGULATION; PROMOTER REGIONS, GENETIC; RETROVIRIDAE INFECTIONS; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS; ZINC FINGERS;

EID: 84862505687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039159     Document Type: Article

References (35)

1. Gao G, Guo X, Goff SP, (2002) Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297: 1703-1706.
2. Bick MJ, Carroll JW, Gao G, Goff SP, Rice CM, et al. (2003) Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol 77: 11555-11562.
3. Muller S, Moller P, Bick MJ, Wurr S, Becker S, et al. (2007) Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol 81: 2391-2400.
4. Zhu Y, Chen G, Lv F, Wang X, Ji X, et al. (2011) Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc Natl Acad Sci U S A 108: 15834-15839.
5. Guo X, Carroll JW, Macdonald MR, Goff SP, Gao G, (2004) The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J Virol 78: 12781-12787.
6. Guo X, Ma J, Sun J, Gao G, (2007) The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA. Proc Natl Acad Sci U S A 104: 151-156.
7. Chen G, Guo X, Lv F, Xu Y, Gao G, (2008) p72 DEAD box RNA helicase is required for optimal function of the zinc-finger antiviral protein. Proc Natl Acad Sci U S A 105: 4352-4357.
8. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2: e25.
9. Switzer WM, Jia H, Zheng H, Tang S, Heneine W, (2011) No association of xenotropic murine leukemia virus-related viruses with prostate cancer. PLoS One 6: e19065.
10. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, et al. (2009) Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 6: 92.
11. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, et al. (2008) Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 43: 277-283.
12. Sakuma T, Hue S, Squillace KA, Tonne JM, Blackburn PR, et al. (2011) No evidence of XMRV in prostate cancer cohorts in the Midwestern United States. Retrovirology 8: 23.
13. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
14. Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S, et al. (2010) Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 7: 10.
15. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, et al. (2010) Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 5: e8519.
16. Furuta RA, Miyazawa T, Sugiyama T, Kuratsune H, Ikeda Y, et al. (2011) No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology 8: 20.
17. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, et al. (2011) No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 333: 94-97.
18. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, et al. (2011) Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science 334: 814-817.
19. Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, et al. (2011) Recombinant origin of the retrovirus XMRV. Science 333: 97-101.
20. Rodriguez JJ, Goff SP, (2010) Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J Virol 84: 2556-2562.
21. Groom HC, Yap MW, Galao RP, Neil SJ, Bishop KN, (2010) Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc Natl Acad Sci U S A 107: 5166-5171.
22. Smith RA, Gottlieb GS, Miller AD, (2010) Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. Retrovirology 7: 70.
23. Li M, Dimaio F, Zhou D, Gustchina A, Lubkowski J, et al. (2011) Crystal structure of XMRV protease differs from the structures of other retropepsins. Nat Struct Mol Biol 18: 227-229.
24. Cote M, Zheng YM, Liu SL, (2012) Membrane Fusion and Cell Entry of XMRV Are pH-Independent and Modulated by the Envelope Glycoprotein's Cytoplasmic Tail. PLoS One 7: e33734.
25. Kerns JA, Emerman M, Malik HS, (2008) Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet 4: e21.
26. Hayakawa S, Shiratori S, Yamato H, Kameyama T, Kitatsuji C, et al. (2011) ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat Immunol 12: 37-44.
27. Wolf D, Goff SP, (2008) Host restriction factors blocking retroviral replication. Annu Rev Genet 42: 143-163.
28. Goila-Gaur R, Strebel K, (2008) HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5: 51.
29. Nakayama EE, Shioda T, (2010) Anti-retroviral activity of TRIM5 alpha. Rev Med Virol 20: 77-92.
30. Best S, Le Tissier P, Towers G, Stoye JP, (1996) Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382: 826-829.
31. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, et al. (2009) Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139: 499-511.
32. Chen S, Xu Y, Zhang K, Wang X, Sun J, et al. (2012) Structure of N-terminal domain of ZAP indicates how a zinc-finger protein recognizes complex RNA. Nat Struct Mol Biol.
33. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
34. Hirt B, (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26: 365-369.
35. Goff S, Traktman P, Baltimore D, (1981) Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol 38: 239-248.